Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis
Mélanie Drolet, Jean‐François Laprise, Dave Martin, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 11, pp. 1598-1610
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Gender neutral HPV vaccination programs: Reconsidering policies to expand cancer prevention globally
J. Andrew Dykens, Caryn E. Peterson, Hunter K. Holt, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 45
Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis
Kiesha Prem, Yoon Hong Choi, Élodie Bénard, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 32
Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study
Irene Man, Damien Georges, Tiago M. de Carvalho, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 11, pp. 1419-1429
Open Access | Times Cited: 36
HPV vaccination and HPV-related malignancies: impact, strategies and optimizations toward global immunization coverage
Gaia Giannone, Anna R. Giuliano, Marco Bandini, et al.
Cancer Treatment Reviews (2022) Vol. 111, pp. 102467-102467
Closed Access | Times Cited: 31
Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis
Élodie Bénard, Mélanie Drolet, Jean‐François Laprise, et al.
The Lancet Public Health (2023) Vol. 8, Iss. 10, pp. e788-e799
Open Access | Times Cited: 21
Parental willingness of HPV vaccination in Mainland China: A meta-analysis
Sensen Tan, Sumeng Wang, Xunwen Zou, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 6
Impact, cost-effectiveness, and budget implications of HPV vaccination in Kenya: A modelling study
Valerian Mwenda, Rose Jalang’o, Christine Miano, et al.
Vaccine (2023) Vol. 41, Iss. 29, pp. 4228-4238
Open Access | Times Cited: 14
Trends in research related to vaccine and cancer prevention from 1992 to 2022: A 30-years bibliometric analysis
Luofei Zhang, Kefu Yu, Bin Zhu, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 13
Perceptions and acceptability of HPV vaccination among parents of female adolescents 9–14 in China: A cross-sectional survey based on the theory of planned behavior
Youqin Yi, Shixin Xiu, Naiyang Shi, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 13
Males’ Access to Human Papillomavirus Vaccination in Resource-Limited Settings
Wubishet Gezimu, Firomsa Bekele, Teshome Bekana, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 95-98
Open Access | Times Cited: 4
Cost-Effectiveness of Human Papillomavirus Vaccination in the UK: Two Versus Single-Dose of Nonavalent HPV Vaccination
Youngji Song, Wongyeong Choi, Eunha Shim
American Journal of Preventive Medicine (2024) Vol. 67, Iss. 2, pp. 231-240
Open Access | Times Cited: 4
The impact of vaccine access difficulties on HPV vaccine intention and uptake among female university students in China
Weiyi Wang
International Journal for Equity in Health (2025) Vol. 24, Iss. 1
Open Access
Pay-it-forward strategy reduced HPV vaccine delay and increased uptake among catch-up age girls: A randomized clinical trial
Jing Li, Yifan Li, Qi Chen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The Global Fund, Cervical Cancer, and HPV infections: what can low- and middle-income countries do to accelerate progress by 2030?
Runcie C.W. Chidebe, Alile Osayi, Julie S. Torode
EClinicalMedicine (2025) Vol. 81, pp. 103127-103127
Closed Access
Modelling epidemiological and economics processes – the case of cervical cancer
F Taeger, Lena Mende, Steffen Fleßa
Health Economics Review (2025) Vol. 15, Iss. 1
Open Access
Predictors of willingness of HPV vaccine uptake across Eight States in Nigeria
Hilary I. Okagbue, Grace Erekosima, Sidney Sampson, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Methodological Approaches for Incorporating Marginalized Populations into HPV Vaccine Modeling: A Systematic Review
Jennifer C. Spencer, Juan Yanguela, Lisa P. Spees, et al.
Medical Decision Making (2025)
Closed Access
Strategically striving to be more inclusive: A recommendation for gender-neutral human-papillomavirus vaccine policies
Mary Jue Xu, Samuel Okerosi, Aslam Nkya, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Advances in Cancer Vaccines: From Traditional Platforms to Nanotechnology Innovations
Nanasaheb D. Thorat
(2025), pp. 1-50
Closed Access
Estimating the effect of HIV on cervical cancer elimination in South Africa: Comparative modelling of the impact of vaccination and screening
Marie‐Claude Boily, Ruanne V. Barnabas, Minttu M. Rönn, et al.
EClinicalMedicine (2022) Vol. 54, pp. 101754-101754
Open Access | Times Cited: 16
Effect of vaccination patterns and vaccination rates on the spread and mortality of the COVID-19 pandemic
Yi-Tui Chen
Health Policy and Technology (2022) Vol. 12, Iss. 1, pp. 100699-100699
Open Access | Times Cited: 16
Long non-coding RNAs as critical regulators and novel targets in cervical cancer: current status and future perspectives
Shalu Ranga, Ritu Yadav, Ravindresh Chhabra, et al.
APOPTOSIS (2023) Vol. 28, Iss. 7-8, pp. 925-942
Open Access | Times Cited: 10
Projected Time for the Elimination of Cervical Cancer Under Various Intervention Scenarios: Age-Period-Cohort Macrosimulation Study
Yi‐Chu Chen, Yun‐Yuan Chen, Shih‐Yung Su, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e46360-e46360
Open Access | Times Cited: 3
Optimal allocation strategies for HPV vaccination introduction and expansion in China accommodated to different supply and dose schedule scenarios: a modelling study
Tingting You, Xuelian Zhao, Shangying Hu, et al.
EClinicalMedicine (2022) Vol. 56, pp. 101789-101789
Open Access | Times Cited: 12
Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India
T. M. de Carvalho, Irene Man, Damien Georges, et al.
BMJ Global Health (2023) Vol. 8, Iss. 11, pp. e012580-e012580
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top